> top > docs > PubMed:33129635 > annotations

PubMed:33129635 JSON TXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id	Subject	Object	Predicate	Lexical cue	fma_id
T1	721-725	Body_part	denotes	face	http://purl.org/sig/ont/fma/fma24728
T2	729-733	Body_part	denotes	face	http://purl.org/sig/ont/fma/fma24728

LitCovid-PD-UBERON

Id	Subject	Object	Predicate	Lexical cue	uberon_id
T1	721-725	Body_part	denotes	face	http://purl.obolibrary.org/obo/UBERON_0001456
T2	729-733	Body_part	denotes	face	http://purl.obolibrary.org/obo/UBERON_0001456

LitCovid-PD-MONDO

Id	Subject	Object	Predicate	Lexical cue	mondo_id
T1	0-8	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T2	354-362	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T3	523-526	Disease	denotes	MAT	http://purl.obolibrary.org/obo/MONDO_0017988
T4	613-621	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T5	1014-1017	Disease	denotes	MAT	http://purl.obolibrary.org/obo/MONDO_0017988
T6	1167-1170	Disease	denotes	MAT	http://purl.obolibrary.org/obo/MONDO_0017988
T7	1265-1273	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096
T8	1350-1353	Disease	denotes	MAT	http://purl.obolibrary.org/obo/MONDO_0017988
T9	1416-1419	Disease	denotes	MAT	http://purl.obolibrary.org/obo/MONDO_0017988
T10	1506-1514	Disease	denotes	COVID-19	http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id	Subject	Object	Predicate	Lexical cue
T1	62-63	http://purl.obolibrary.org/obo/CLO_0001020	denotes	a
T2	648-649	http://purl.obolibrary.org/obo/CLO_0001020	denotes	a
T3	721-725	http://purl.obolibrary.org/obo/UBERON_0001456	denotes	face
T4	729-733	http://purl.obolibrary.org/obo/UBERON_0001456	denotes	face
T5	1059-1060	http://purl.obolibrary.org/obo/CLO_0001020	denotes	a

LitCovid-PD-GO-BP

Id	Subject	Object	Predicate	Lexical cue
T1	81-89	http://purl.obolibrary.org/obo/GO_0015297	denotes	exchange
T2	99-107	http://purl.obolibrary.org/obo/GO_0015297	denotes	exchange
T3	756-764	http://purl.obolibrary.org/obo/GO_0015297	denotes	exchange
T4	1478-1486	http://purl.obolibrary.org/obo/GO_0015297	denotes	exchange

LitCovid-PubTator

Id	Subject	Object	Predicate	Lexical cue	tao:has_database_id
1	0-8	Disease	denotes	COVID-19	MESH:C000657245
12	108-116	Species	denotes	patients	Tax:9606
13	354-362	Disease	denotes	COVID-19	MESH:C000657245
14	613-621	Disease	denotes	COVID-19	MESH:C000657245
15	765-773	Species	denotes	patients	Tax:9606
16	933-940	Species	denotes	patient	Tax:9606
17	1136-1144	Species	denotes	patients	Tax:9606
18	1265-1273	Disease	denotes	COVID-19	MESH:C000657245
19	1313-1320	Species	denotes	patient	Tax:9606
20	1487-1495	Species	denotes	patients	Tax:9606
21	1506-1514	Disease	denotes	COVID-19	MESH:C000657245

LitCovid-sentences

Id	Subject	Object	Predicate	Lexical cue
T1	0-90	Sentence	denotes	COVID-19 innovations in medication for addiction treatment at a Skid Row syringe exchange.
T2	91-363	Sentence	denotes	Syringe exchange patients in Los Angeles' Skid Row endure conditions such as deep poverty, polysubstance use, underlying health problems, and living on the streets or in homeless encampments/shelters that make them uniquely vulnerable to acquiring and dying from COVID-19.
T3	364-622	Sentence	denotes	In this commentary, we discuss two essential changes that Homeless Health Care Los Angeles (HHCLA) made to modify existing medication for addiction treatment (MAT) services to address the specific treatment needs of this high-risk population during COVID-19.
T4	623-952	Sentence	denotes	First, HHCLA implemented a novel "telephone booth" model that allowed socially distanced on-site "face-to-face" treatment of syringe exchange patients; this model helped us to overcome the inherent challenges of using traditional telemedicine approaches (e.g., video, mobile telephone) with this disadvantaged patient population.
T5	953-1222	Sentence	denotes	Second, HHCLA transitioned from on-site direct dispensing of MAT medications in our providers' offices to a less contact- and time-intensive "coordinated pharmacy" model that allowed patients the freedom to obtain MAT medications off-site from participating pharmacies.
T6	1223-1515	Sentence	denotes	Our data indicate that implementing these COVID-19-related changes effectively maintained patient enrollment and engagement in MAT-illuminating new, potentially effective models for delivering MAT that meet the critical health and safety needs of syringe exchange patients following COVID-19.